These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 21632883)

  • 1. Syndecan-4 signalling inhibits apoptosis and controls NFAT activity during myocardial damage and remodelling.
    Echtermeyer F; Harendza T; Hubrich S; Lorenz A; Herzog C; Mueller M; Schmitz M; Grund A; Larmann J; Stypmann J; Schieffer B; Lichtinghagen R; Hilfiker-Kleiner D; Wollert KC; Heineke J; Theilmeier G
    Cardiovasc Res; 2011 Oct; 92(1):123-31. PubMed ID: 21632883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
    See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
    J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiomyocyte-specific overexpression of syndecan-4 in mice results in activation of calcineurin-NFAT signalling and exacerbated cardiac hypertrophy.
    Lunde IG; Aronsen JM; Melleby AO; Strand ME; Skogestad J; Bendiksen BA; Ahmed MS; Sjaastad I; Attramadal H; Carlson CR; Christensen G
    Mol Biol Rep; 2022 Dec; 49(12):11795-11809. PubMed ID: 36205855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction.
    Kompa AR; See F; Lewis DA; Adrahtas A; Cantwell DM; Wang BH; Krum H
    J Pharmacol Exp Ther; 2008 Jun; 325(3):741-50. PubMed ID: 18334667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced expression of DYRK1A in cardiomyocytes inhibits acute NFAT activation but does not prevent hypertrophy in vivo.
    Grebe C; Klingebiel TM; Grau SP; Toischer K; Didié M; Jacobshagen C; Dullin C; Hasenfuss G; Seidler T
    Cardiovasc Res; 2011 Jun; 90(3):521-8. PubMed ID: 21273244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of p38alpha MAPK in cardiac apoptosis and remodeling after myocardial infarction.
    Ren J; Zhang S; Kovacs A; Wang Y; Muslin AJ
    J Mol Cell Cardiol; 2005 Apr; 38(4):617-23. PubMed ID: 15808838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular FLICE-inhibitory protein protects against cardiac remodelling after myocardial infarction.
    Xiao J; Moon M; Yan L; Nian M; Zhang Y; Liu C; Lu J; Guan H; Chen M; Jiang D; Jiang H; Liu PP; Li H
    Basic Res Cardiol; 2012 Jan; 107(1):239. PubMed ID: 22202974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction.
    Morimoto H; Takahashi M; Izawa A; Ise H; Hongo M; Kolattukudy PE; Ikeda U
    Circ Res; 2006 Oct; 99(8):891-9. PubMed ID: 16990567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term aerobic exercise protects the heart against ischemia/reperfusion injury via PI3 kinase-dependent and Akt-mediated mechanism.
    Zhang KR; Liu HT; Zhang HF; Zhang QJ; Li QX; Yu QJ; Guo WY; Wang HC; Gao F
    Apoptosis; 2007 Sep; 12(9):1579-88. PubMed ID: 17505785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcineurin Abeta gene targeting predisposes the myocardium to acute ischemia-induced apoptosis and dysfunction.
    Bueno OF; Lips DJ; Kaiser RA; Wilkins BJ; Dai YS; Glascock BJ; Klevitsky R; Hewett TE; Kimball TR; Aronow BJ; Doevendans PA; Molkentin JD
    Circ Res; 2004 Jan; 94(1):91-9. PubMed ID: 14615291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of prostaglandin EP3 receptors activates calcineurin and promotes hypertrophy in the murine heart.
    Meyer-Kirchrath J; Martin M; Schooss C; Jacoby C; Flögel U; Marzoll A; Fischer JW; Schrader J; Schrör K; Hohlfeld T
    Cardiovasc Res; 2009 Feb; 81(2):310-8. PubMed ID: 19019835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth differentiation factor 5 regulates cardiac repair after myocardial infarction.
    Zaidi SH; Huang Q; Momen A; Riazi A; Husain M
    J Am Coll Cardiol; 2010 Jan; 55(2):135-43. PubMed ID: 20117381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propofol post-conditioning protects against cardiomyocyte apoptosis in hypoxia/reoxygenation injury by suppressing nuclear factor-kappa B translocation via extracellular signal-regulated kinase mitogen-activated protein kinase pathway.
    Li H; Tan J; Zou Z; Huang CG; Shi XY
    Eur J Anaesthesiol; 2011 Jul; 28(7):525-34. PubMed ID: 21666544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury.
    Kempf T; Eden M; Strelau J; Naguib M; Willenbockel C; Tongers J; Heineke J; Kotlarz D; Xu J; Molkentin JD; Niessen HW; Drexler H; Wollert KC
    Circ Res; 2006 Feb; 98(3):351-60. PubMed ID: 16397141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
    Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
    Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory role of CARD3 in left ventricular remodelling and dysfunction after myocardial infarction.
    Li L; Wang X; Chen W; Qi H; Jiang DS; Huang L; Huang F; Wang L; Li H; Chen X
    Basic Res Cardiol; 2015 Nov; 110(6):56. PubMed ID: 26463597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of endogenous Mst1 prevents apoptosis and cardiac dysfunction without affecting cardiac hypertrophy after myocardial infarction.
    Odashima M; Usui S; Takagi H; Hong C; Liu J; Yokota M; Sadoshima J
    Circ Res; 2007 May; 100(9):1344-52. PubMed ID: 17395874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
    Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD
    Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor Fn14 during cardiac remodelling in rats.
    Mustonen E; Säkkinen H; Tokola H; Isopoussu E; Aro J; Leskinen H; Ruskoaho H; Rysä J
    Acta Physiol (Oxf); 2010 May; 199(1):11-22. PubMed ID: 20082609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptin signalling reduces the severity of cardiac dysfunction and remodelling after chronic ischaemic injury.
    McGaffin KR; Sun CK; Rager JJ; Romano LC; Zou B; Mathier MA; O'Doherty RM; McTiernan CF; O'Donnell CP
    Cardiovasc Res; 2008 Jan; 77(1):54-63. PubMed ID: 18006469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.